Several overseas research institutes have conducted “replication studies” using N-NOSE, the world’s first biological screening technology, focusing on the reproducibility of our method.
The research confirmed that the technology is reproducible as a method of identifying cancer with great accuracy, and results have been published in academic journals.
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .
2023.03.20HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. －Pre-order available, special discounts ar . . .
2023.03.10Our CEO made a courtesy call on Minister Yasutoshi Nishimura.
2023.02.27